They sue me because the medicine is illegal, but if it is legal, they say I can't afford it?

Chapter 393: Unpredictable



Chapter 393: Unpredictable

……

Novartis!

CEO's office!

"$3000 billion?"

"Could the price even rise to $4000 billion in a month?"

"Hmm...$5000 billion in another month?"

Upon hearing the news,

Anna's head was buzzing.

She knew that Antai Pharmaceutical Group was very valuable and had promising future development prospects. If she wanted to acquire Antai Pharmaceutical Group now, she would definitely have to pay a premium.

She was mentally prepared for this.

But she still didn't expect that Chen Xuan would ask for 3000 billion US dollars right away, and this is the current price.

If you don't acquire it now, it will be $4000 billion in a month, and $5000 billion in another month.

In short, it increased by $1000 billion in one month.

Anna was so shocked by the price that she was speechless.

Even if it is a premium acquisition, it shouldn't be so exaggerated. This is too inconsistent with market rules.

However, this interview did change many of her ideas, and all her plans also changed quietly.

"At $3000 billion, it seems the acquisition is out of the question."

"AbbVie, Johnson & Johnson, and Mosadone have been hyped for so long, I wonder what they are feeling now."

After thinking about this, Anna couldn't help laughing again.

When Chen Xuan said that the patent for the lung cancer drug was worth $1000 billion, she had already given up the idea of ​​acquiring it.

Whether it was the patent for a special lung cancer drug or Antai Real Estate Group, she knew it was impossible for her to acquire it.

After all, Chen Xuan is really not short of money, and Antai Pharmaceutical Group is not short of money either. In addition, with the official support of China, they are even less short of money.

In this case, there is no hope of acquiring it unless a high premium is offered.

Especially when he said that he wanted to acquire a special drug for lung cancer and that he would need to prepare $1000 billion, she knew that there was no hope.

Not to mention acquiring Antai Pharmaceutical Group, even if he wanted to acquire shares, he couldn't do it. He had no shortage of funds and no idea of ​​raising funds.

So, Anna not only gave up herself, but also asked the Novartis board of directors to give up the idea, telling them not to think about it anymore and that it was a waste of time.

Later, news suddenly broke that the three giants, Johnson & Johnson, Mosadone, and AbbVie, would join forces to acquire Aetna Pharmaceuticals Group.

This suddenly made Anna feel a little interesting, and she also watched the matter.

The outside world doesn't know whether it's true or not, but she is quite clear about this matter.

The rumors are both true and false, and they were deliberately spread by three pharmaceutical giants: Johnson & Johnson, AbbVie, and Mosadone.

The purpose of the dissemination was to push up the stock prices of the three giants, and in fact it was successful. The news of the acquisition of Antai Pharmaceutical Group caused the stock prices of the three giants to rise significantly.

The market is indeed very optimistic about Antai Pharmaceutical Group and believes that whoever acquires Antai Pharmaceutical Group will have a bright future.

This news has made pharmaceutical giants such as Novartis quite nervous.

Anna is worried that after the previous pharmaceutical giant acquires Antai Pharmaceutical Group, it will form a monopoly trend in the pharmaceutical industry, its competitiveness will become stronger, and the situation of other competitors will become more difficult.

Novartis, in particular, could have been the agent for Aetna Pharmaceuticals Group's drugs and had an exclusive overseas agency contract.

But if it is acquired by the three pharmaceutical giants, Novartis will lose the agency contract and will no longer be able to represent Aetna Pharmaceutical Group's drugs.

Moreover, once the three companies join forces to acquire the company, they will surely become close allies in the future.

The strength of any of the three companies is terrifying, and now that they are united together, they are even more powerful than giants.

Because of this, this news has caused anxiety in the entire industry, and many pharmaceutical giants are holding meetings overnight, including Novartis.

Anna has been very busy with this matter these days.

But now, after hearing that Chen Xuan's offer was 3000 billion US dollars, Anna felt relieved instantly.

It is basically impossible for the three pharmaceutical giants, Mosadone, Johnson & Johnson, and AbbVie, to agree to the price of US$3000 billion.

It is also difficult for them to come up with $3000 billion in cash.

"Chen Xuan is a really interesting person."

"First, we had a battle with Pfizer, and now it has escalated to a lawsuit."

"Now they're going up against Johnson & Johnson, AbbVie, and Mosadone again, using $3000 billion to eliminate them. What a brilliant idea!"

After feeling relieved, Anna looked towards the east and muttered with interest.

That's right, she believed that the reason why Chen Xuan offered a price of 3000 billion US dollars was to scare off Johnson & Johnson, AbbVie, and Mosadone.

The reason for this price is not that he thinks Antai Pharmaceutical Group is worth so much money, but that he does not want to sell Antai Pharmaceutical Group, so he deliberately offers such a sky-high price so that the other party will give up.

So, this made Anna feel very interesting.

Now she is becoming more and more curious about what Chen Xuan is pursuing.

Although he is not a businessman, he is indeed focused on making money.

But if he is a businessman, many of his behaviors are inconsistent with those of a businessman, and even go against the grain of a businessman.

In short, in Anna's eyes, Chen Xuan is a very contradictory combination. Perhaps she has not seen through his essence yet, so she doesn't know what kind of person he is.

"Chen Xuan has a new medicine."

"The new drug he told me about earlier has been successful. The speed of its development is truly outrageous!"

"And I was right. He has more than one new drug project, and he succeeded in two at once. That's terrifying."

Anna suddenly thought of this again.

She was more shocked by the success of Chen Xuan's new drug project than the $3000 billion acquisition.

Chen Xuan's speed in developing new drugs is simply abnormal.

Novartis invests tens of billions of dollars in research and development every year, and has countless top scientific researchers, but its achievements cannot be compared with those of Chen Xuan alone.

It's not just the quantity, the quality is also very different.

Every medical achievement of Chen Xuan is a world-class medical achievement, which is far beyond the reach of Novartis.

Touching her chin, Anna rolled her eyes and suddenly had an idea in her mind.

Chen Xuan's new drug research was successful, and she had to take action.

……

Anna is not the only one paying attention to this matter.

Almost everyone in the pharmaceutical industry around the world is paying attention to this matter.

Qin Guoming and others were so jealous that their hair turned purple.

As for the people who were directly affected by this incident, it is naturally Mosatrol, AbbVie, and Johnson & Johnson.

After Chen Xuan quoted the price, the stocks of the three giants, which had originally risen slightly, suddenly fell back, and even fell lower than before.

But faced with this situation, the three companies did not respond, as if they were just spectators.

……


Tip: You can use left, right, A and D keyboard keys to browse between chapters.